Exenatide improves antioxidant capacity and reduces the expression of LDL receptors and PCSK9 in human insulin-secreting 1.1E7 cell line subjected to hyperglycemia and oxidative stress
Łukasz Bułdak
Department of Internal Medicine and Clinical Pharmacology, School of Medicine in Katowice, Medical University of SilesiaKatowice, Poland
Profil OrcidRecherchez cet auteur sur
, Estera Skudrzyk
Department of Internal Medicine and Clinical Pharmacology, School of Medicine in Katowice, Medical University of SilesiaKatowice, Poland
Profil OrcidRecherchez cet auteur sur
, Grzegorz Machnik
Department of Internal Medicine and Clinical Pharmacology, School of Medicine in Katowice, Medical University of SilesiaKatowice, Poland
Profil OrcidRecherchez cet auteur sur
, Aleksandra Bołdys
Department of Internal Medicine and Clinical Pharmacology, School of Medicine in Katowice, Medical University of SilesiaKatowice, Poland
Profil OrcidRecherchez cet auteur sur
, Rafał Jakub Bułdak
Institute of Medical Sciences, University of OpoleOpole, Poland
Profil OrcidRecherchez cet auteur sur
et Bogusław Okopień
Department of Internal Medicine and Clinical Pharmacology, School of Medicine in Katowice, Medical University of SilesiaKatowice, Poland
Profil OrcidRecherchez cet auteur sur
20 févr. 2022
À propos de cet article